Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Endo International plc
Current Parent CompanyEndo International
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $2,300,000
Year: 2019
Date: July 25, 2019
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Endo International plc and Endo Pharmaceuticals Inc. agreed to pay $2.3 million to resolve multistate litigation alleging anti-competitive, "pay-for-delay" conduct related to Endo's sale of Lidoderm, a pain-relief drug that treats complications from shingles.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Ireland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.